BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35598422)

  • 41. Assemblies of salen-type oxidovanadium(IV) complexes: substituent effects and in vitro protein tyrosine phosphatase inhibition.
    Zabierowski P; Szklarzewicz J; Gryboś R; Modryl B; Nitek W
    Dalton Trans; 2014 Dec; 43(45):17044-53. PubMed ID: 25303031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complexes of cis-dioxomolybdenum(VI) and oxovanadium(IV) with a tridentate ONS donor ligand: synthesis, spectroscopic properties, X-ray crystal structure and catalytic activity.
    Fayed AM; Elsayed SA; El-Hendawy AM; Mostafa MR
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Aug; 129():293-302. PubMed ID: 24747851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis, characterization, reactivity and catalytic activity of oxidovanadium(IV), oxidovanadium(V) and dioxidovanadium(V) complexes of benzimidazole modified ligands.
    Maurya MR; Bisht M; Kumar A; Kuznetsov ML; Avecilla F; Pessoa JC
    Dalton Trans; 2011 Jul; 40(26):6968-83. PubMed ID: 21647507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydrolytically Stable Ti
    Sahu G; Sahu K; Patra SA; Mohapatra D; Khangar R; Sengupta S; Dinda R
    ACS Appl Bio Mater; 2023 Dec; 6(12):5360-5371. PubMed ID: 38019535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monomeric and Dimeric Oxidomolybdenum(V and VI) Complexes, Cytotoxicity, and DNA Interaction Studies: Molybdenum Assisted C═N Bond Cleavage of Salophen Ligands.
    Majumder S; Pasayat S; Panda AK; Dash SP; Roy S; Biswas A; Varma ME; Joshi BN; Garribba E; Kausar C; Patra SK; Kaminsky W; Crochet A; Dinda R
    Inorg Chem; 2017 Sep; 56(18):11190-11210. PubMed ID: 28858483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, Biomacromolecular Interactions, Photodynamic NO Releasing and Cellular Imaging of Two [RuCl(qn)(Lbpy)(NO)]X Complexes.
    Song L; Bai H; Liu C; Gong W; Wang A; Wang L; Zhao Y; Zhao X; Wang H
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33925453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mixed ligand cobalt(II) picolinate complexes: synthesis, characterization, DNA binding and photocleavage.
    Kawade VA; Kumbhar AA; Kumbhar AS; Näther C; Erxleben A; Sonawane UB; Joshi RR
    Dalton Trans; 2011 Jan; 40(3):639-50. PubMed ID: 21127806
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and structure of mono-, bi- and trimetallic amine-bis(phenolate) cobalt(II) complexes.
    Das UK; Bobak J; Fowler C; Hann SE; Petten CF; Dawe LN; Decken A; Kerton FM; Kozak CM
    Dalton Trans; 2010 Jun; 39(23):5462-77. PubMed ID: 20480065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, X-Ray Crystal Structures and Catalytic Epoxidation of Oxidovanadium(V) Complexes with Aroylhydrazone and Ethyl Maltolate Ligands.
    Zou DH; Liang M; Chen W
    Acta Chim Slov; 2021 Jun; 68(2):441-446. PubMed ID: 34738140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-dimensional compounds containing bioactive ligands. XXII. First crystal structure, cytotoxic activity and DNA and HSA binding of a zirconium(IV) complex with 8-hydroxyquinoline-2-carboxylic acid.
    Harmošová M; Vilková M; Kello M; Smolko L; Samol'ová E; Šebová D; Potočňák I
    Acta Crystallogr C Struct Chem; 2023 Aug; 79(Pt 8):316-323. PubMed ID: 37466222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
    Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experimental and theoretical investigations of novel oxidovanadium(IV) juglone complex: DNA/HSA interaction and cytotoxic activity.
    Abyar F; Tabrizi L
    J Biomol Struct Dyn; 2020 Feb; 38(2):474-487. PubMed ID: 30831056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 1. Coordination modes and geometry in solution and at the physiological pH.
    Sanna D; Ugone V; Lubinu G; Micera G; Garribba E
    J Inorg Biochem; 2014 Nov; 140():173-84. PubMed ID: 25127230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monomeric oxovanadium(IV) compounds of the general formula cis-[V(IV)(=O)(X)(L(NN))(2)](+/0) [X = OH(-), Cl(-), SO(4)(2)(-) and L(NN) = 2,2'-bipyridine (bipy) or 4,4'-disubstituted bipy].
    Triantafillou GD; Tolis EI; Terzis A; Deligiannakis Y; Raptopoulou CP; Sigalas MP; Kabanos TA
    Inorg Chem; 2004 Jan; 43(1):79-91. PubMed ID: 14704056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring the cytotoxic activity of new phenanthroline salicylaldimine Zn(II) complexes.
    Matos CP; Addis Y; Nunes P; Barroso S; Alho I; Martins M; Matos APA; Marques F; Cavaco I; Costa Pessoa J; Correia I
    J Inorg Biochem; 2019 Sep; 198():110727. PubMed ID: 31195153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Zn(phen)(O,N,O)(H2O)] and [Zn(phen)(O,N)(H2O)] with O,N,O is 2,6-dipicolinate and N,O is L-threoninate: synthesis, characterization, and biomedical properties.
    Chin LF; Kong SM; Seng HL; Tiong YL; Neo KE; Maah MJ; Khoo AS; Ahmad M; Hor TS; Lee HB; San SL; Chye SM; Ng CH
    J Biol Inorg Chem; 2012 Oct; 17(7):1093-105. PubMed ID: 22825726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Example of two novel thiocyanato bridged copper (II) complexes derived from substituted thiosemicarbazone ligand: structural elucidation, DNA/albumin binding, biological profile analysis, and molecular docking study.
    Biswas N; Saha S; Khanra S; Sarkar A; Prasad Mandal D; Bhattacharjee S; Chaudhuri A; Chakraborty S; Roy Choudhury C
    J Biomol Struct Dyn; 2019 Jul; 37(11):2801-2822. PubMed ID: 30101692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, characterization, HSA/DNA interactions and antitumor activity of new [Ru(η
    Đukić MB; Jeremić MS; Filipović IP; Klisurić OR; Kojić VV; Jakimov DS; Jelić RM; Onnis V; Matović ZD
    J Inorg Biochem; 2020 Dec; 213():111256. PubMed ID: 32980642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel V(IV)O-pyrimidinone complex: synthesis, solution speciation and human serum protein binding.
    Gonçalves G; Tomaz I; Correia I; Veiros LF; Castro MM; Avecilla F; Palacio L; Maestro M; Kiss T; Jakusch T; Garcia MH; Pessoa JC
    Dalton Trans; 2013 Sep; 42(33):11841-61. PubMed ID: 23677414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ligand substitution reactions of a phenolic quinolyl hydrazone; oxidovanadium (IV) complexes.
    Seleem HS; Mousa MA
    Chem Cent J; 2011 Aug; 5(1):47. PubMed ID: 21846387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.